Molecular association model of PPARα and its new specific and efficient ligand, pemafibrate: Structural basis for SPPARMα
2018
Abstract Peroxisome proliferator-activated receptor-α (PPARα) is a ligand-
activated transcription factorinvolved in the regulation of lipid homeostasis and improves
hypertriglyceridemia. Pemafibrate is a novel selective PPARα modulator (SPPARMα) that activates PPARα transcriptional activity. Here, we computationally constructed the structure of the human PPARα in a complex with pemafibrate, along with that of hPPARα complexed with the classical
fenofibrate, and studied their interactions quantitatively by using the first-principles calculations-based
fragment molecular orbital(FMO) method. Comprehensive structural and
protein-ligandbinding elucidation along with the in vitro
luciferaseanalysis let us to identify pemafibrate as a novel SPPARMα. Unlike known
fibrateligands, which bind only with the arm I of the Y-shaped ligand binding pocket, the Y-shaped pemafibrate binds to the entire cavity region. This lock and key nature causes enhanced induced fit in pemafibrate-ligated PPARα. Importantly, this selective modulator allosterically changes PPARα conformation to form a brand-new interface, which in turn binds to PPARα co-activator, PGC-1α, resulting in the full activation of PPARα. The structural basis for the potent effects of pemafibrate on PPARα transcriptional activity predicted by the in silico FMO methods was confirmed by in vitro
luciferaseassay for mutants. The unique binding mode of pemafibrate reveals a new pattern of nuclear receptor ligand recognition and suggests a novel basis for ligand design, offering cues for improving the binding affinity and selectivity of ligand for better clinical consequences. The findings explain the high affinity and efficacy of pemafibrate, which is expected to be in the clinical use soon.
Keywords:
-
Correction
-
Source
-
Cite
-
Save
17
References
35
Citations
NaN
KQI